Akiko Nagamachi¹, Hirotaka Matsui², Akinori Kanai³, Satoru Shinriki², Toshiya Inaba³ (1.Radiation Research Center, RIRBM, Hiroshima Univ., Japan, 2.Graduate School of Medical Sciences, Kumamoto Univ., Japan, 3.Division of Molecular Oncology, RIRBM, Hiroshima Univ., Japan)

Masanori Yoshida^1,2, Kanako Nakao³, Hirohito Shima³, Ryota Shirai^1,2, Kaoru Yoshida¹, Shinichi Tsujimoto^1,2, Tomoo Osumi^1,4, Takao Deguchi⁴, Makiko Mori⁵, Yuki Arakawa⁵, Masatoshi Takagi⁶, Takako Miyamura⁷, Kimiyoshi Sakaguchi⁸, Hidemi Toyoda⁹, Hisashi Ishida¹⁰, Naoki Sakata¹¹, Toshihiko Imamura¹², Yuta Kawahara¹³, Takashi Koike¹⁴, Daisuke Tomizawa⁴, Nobutaka Kiyokawa¹, Satoshi Narumi³, Motohiro Kato^1,4 (1.Department of Pediatric Hematology and Oncology Research, NCCHD, Tokyo, Japan, 2.Department of Pediatrics, Yokohama City University, 3.Department of Molecular Endocrinology, NCCHD, Tokyo, Japan, 4.Children's Cancer Center, NCCHD, Tokyo, Japan, 5.Department of Hematology/Oncology, SCMC, Saitama, Japan, 6.Department of Pediatrics, Tokyo Medical Dental University, Tokyo, Japan, 7.Department of Pediatrics, Osaka University, Osaka, Japan, 8.Pediatrics, Hamamatsu University School of Medicine, Shizuoka, Japan, 9.Pediatrics, Mie University, Mie, Japan, 10.Department of Pediatrics, Okayama University Hospital, Okayama, Japan, 11.Departments of Pediatrics, Kindai University Faculty of Medicine, Osaka, Japan, 12.Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan, 13.Department of Pediatrics, Jichi Medical University, 14.Department of Pediatrics, Tokai University School of Medicine, Kanagawa, Japan)

Yusuke Okuno¹, Hideki Muramatsu², Norihiro Murakami², Manabu Wakamatsu², Hironobu Kitazawa², Tomoo Ogi³, Yoshiyuki Takahashi² (1.Medical Genomics Center, Nagoya University Hospital, Nagoya, Japan, 2.Department of Pediatrics, Nagoya University, Nagoya, Japan, 3.Department of Genetics, RIeM, Nagoya University, Nagoya, Japan)

Yoshihiro Hayashi¹, Yasushige Aoyagi¹, Naoki Shingai¹, Yuka Harada², Hironori Harada¹ (1.Lab. Oncology, Tokyo University of Pharmacy & Life Sciences, Tokyo, Japan, 2.Clinical Research Support Center, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan)

Masanori Motomura¹, Yoshikage Inoue¹, Yasunobu Nagata¹, Tetsuichi Yoshizato¹, Constance Baer², Yukihide Momozawa³, Niroshan Nadarajah², Tamara Alpermann², Yasuhito Nanya¹, Kenichi Yoshida¹, Claudia Haferlach², Wolfgang Kern², Yoshiko Atsuta^4,5, Yuka Iijima⁶, Yuichi Shiraishi⁷, Makoto Onizuka⁸, Kenichi Chiba⁷, Hiroko Tanaka⁷, Hidehiro Itonaga⁹, Yasushi Miyazaki⁹, Keizo Horibe⁶, Masashi Sanada^1,6, Yoichiro Kamatani³, Michiaki Kubo³, Satoru Miyano⁷, Torsten Haferlach², Hideki Makishima¹, Seishi Ogawa^1,10 (1.Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan, 2.MLL Munich Leukemia Laboratory, Munich, Germany, 3.Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan, 4.Department of Healthcare Administration, Nagoya University, Nagoya, Japan, 5.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan, 6.National Hospital Organization Nagoya Medical Center, Nagoya, Japan, 7.Human Genome Center, Tokyo University, Tokyo, Japan, 8.Department of Hematology and Oncology, Tokai University, Isehara, Japan, 9.Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan, 10.Center for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden)

Yotaro Ochi^1,2, Ayana Kon¹, Toyonori Sakata³, Masahiro Nakagawa¹, Keisuke Kataoka¹, Haruhiko Koseki⁴, Manabu Nakayama⁵, Ryunosuke Saiki¹, Tetsuichi Yoshizato¹, Kenichi Yoshida¹, Akinori Yoda¹, Shinichi Kotani¹, Hiroshi Suzuki⁶, Daisuke Morishita⁷, Masanori Kakuta⁸, Tatsuaki Tsuruyama⁹, Hideki Makishima¹, Yusuke Shiozawa¹, Yasuhito Nanya¹, Eiji Sugihara¹⁰, Takaaki Sato¹⁰, Masashi Sanada¹¹, Akifumi Takaori², Satoru Miyano⁸, Katsuhiko Shirahige³, Seishi Ogawa¹ (1.Tumor and Pathol., Kyoto Univ, Kyoto, Japan, 2.Hematol and Oncol, Kyoto University, Kyoto, Japan, 3.Lab. of Genome Str and Func., Tokyo univ, Tokyo, Japan, 4.Develop Genet, RIKEN, Yokohama, Japan, 5.Chr Eng Team, Kazusa DNA Res Inst., Kisarazu, Japan, 6.David H. Koch Inst. Cambridge, MA, USA, 7.Chordia Therapeutics Inc, Kanazawa, Japan, 8.Lab of DNA Inf Ana, HGC, Tokyo Univ, Tokyo, Japan, 9.Drug and Discov, Kyoto Univ., Kyoto, Japan, 10.Innov Med Res Inst., Tsukuba Univ., Ibaraki, Japan, 11.Adv Diag, Nagoya Med Center, Nagoya, Japan)